We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

72 hedge funds and large institutions have $28.6M invested in Cue Health Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,746% more call options, than puts

Call options by funds: $240K | Put options by funds: $13K

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

15% more capital invested

Capital invested by funds: $24.8M → $28.6M (+$3.78M)

9% less funds holding

Funds holding: 7972 (-7)

40% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 20

50% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 14

Holders
72
Holders Change
-7
Holders Change %
-8.86%
% of All Funds
1.14%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
7
Increased
12
Reduced
20
Closed
14
Calls
$240K
Puts
$13K
Net Calls
+$227K
Net Calls Change
+$43K
Name Holding Trade Value Shares
Change
Change in
Stake
TC
1
Tarsadia Capital
New York
$4.73M +$4.87M +10,684,791 New
OC
2
Oakmont Corp
California
$4.22M
DCMIC
3
Decheng Capital Management III (Cayman)
Cayman Islands
$3.97M
MA
4
Madrone Advisors
California
$3.13M
JJ
5
Johnson & Johnson
New Jersey
$2.45M
JPC
6
Jabodon PT Co
Nevada
$1.76M
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.72M
Temasek Holdings
8
Temasek Holdings
Singapore
$1.38M
KI
9
Koch Industries
Kansas
$976K -$4.87M -10,670,869 -83%
BlackRock
10
BlackRock
New York
$725K +$90.3K +197,922 +14%
Jacobs Levy Equity Management
11
Jacobs Levy Equity Management
New Jersey
$499K +$111K +243,246 +28%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$453K +$15.9K +34,772 +4%
BL
13
Bleichroeder LP
New York
$442K
Verition Fund Management
14
Verition Fund Management
Connecticut
$387K -$57.4K -125,900 -13%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$297K -$33.9K -74,322 -10%
MP
16
MSD Partners
New York
$175K
Millennium Management
17
Millennium Management
New York
$160K -$43.2K -94,806 -21%
State Street
18
State Street
Massachusetts
$146K
Renaissance Technologies
19
Renaissance Technologies
New York
$143K -$27.9K -61,100 -16%
BRWA
20
B. Riley Wealth Advisors
Florida
$115K +$119K +260,000 New
Invesco
21
Invesco
Georgia
$105K +$922 +2,021 +0.9%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$101K +$104K +227,900 New
Northern Trust
23
Northern Trust
Illinois
$75.3K -$224 -491 -0.3%
AF
24
Allworth Financial
California
$44.2K
Capstone Investment Advisors
25
Capstone Investment Advisors
New York
$40.9K

HLTH Hedge Fund Activity: Q3 2023 in Review

72 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q3 2023, worth a combined $28.6M — up 15% from $24.8M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of HLTH and 7 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 12 added.

The largest buyer was B. Riley Wealth Advisors, opening a new position worth an estimated $119K. The largest seller was Koch Industries, cutting an estimated $4.87M.

  • 72 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q3 2023, down from 79 in Q2 2023.
  • Funds reported $28.6M of Cue Health Inc. Common Stock stock for Q3 2023, up 15% quarter-over-quarter.
  • 7 funds opened new Cue Health Inc. Common Stock positions in Q3 2023 and 14 closed out, a net change of -7 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q3 2023 was B. Riley Wealth Advisors, an estimated $119K added.
  • The largest Cue Health Inc. Common Stock seller in Q3 2023 was Koch Industries, an estimated $4.87M sold.

Based on aggregated 13F filings for Q3 2023.